Back to Insights

CAR-T therapy and historical trends in effectiveness and cost–effectiveness of oncology treatments

By James Baumgarden, PhD

CAR-T therapy breaks a pattern of stagnant efficacy growth in pharmaceutical innovation. A new CAR-T therapy study, by Precision’s James Baumgarden and his study co-authors, demonstrates significantly greater incremental effectiveness and similar cost–effectiveness to previous anticancer treatments.

Read the full article on FutureMedicine